270 related articles for article (PubMed ID: 33313857)
1. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice.
Mizushima I; Yamano T; Kawahara H; Hibino S; Nishioka R; Zoshima T; Hara S; Ito K; Fujii H; Nomura H; Kawano M
Rheumatology (Oxford); 2021 Jul; 60(7):3317-3325. PubMed ID: 33313857
[TBL] [Abstract][Full Text] [Related]
2. What is the meaning of ANCA positivity in IgG4-related disease?
Martín-Nares E; Hernandez-Molina G
Rheumatology (Oxford); 2021 Aug; 60(8):3845-3850. PubMed ID: 33547775
[TBL] [Abstract][Full Text] [Related]
3. The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China.
Liu Z; Nie Y; Peng Y; Lu H; Zhang P; Li J; Sun R; Li J; Sun B; He X; Zhou J; Fei Y; Peng L; Zhang W; Zeng X
Semin Arthritis Rheum; 2023 Aug; 61():152202. PubMed ID: 37167774
[TBL] [Abstract][Full Text] [Related]
4. Performance of the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease in a Large Chinese Cohort.
An ZY; Fu JN; Zeng QZ; Zhufeng YZ; Ning XR; Li HJ; Ma XB; Wang KK; Bian WJ; Zhang YX; Li ZG; Liu YY
J Clin Rheumatol; 2024 Mar; 30(2):73-78. PubMed ID: 38268091
[TBL] [Abstract][Full Text] [Related]
5. Description of patients with IgG4-related disease from a Hungarian centre.
Szántó A; Nagy G; Molnár CS; Griger Z; Tarr T; Zeher M
Scand J Rheumatol; 2014; 43(4):334-7. PubMed ID: 25087687
[TBL] [Abstract][Full Text] [Related]
6. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS; Naden RP; Chari S; Choi H; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Kubota K; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Sekiguchi H; Schleinitz N; Stone JR; Takahashi N; Umehara H; Webster G; Zen Y; Stone JH;
Arthritis Rheumatol; 2020 Jan; 72(1):7-19. PubMed ID: 31793250
[TBL] [Abstract][Full Text] [Related]
7. Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease.
Kogami M; Abe Y; Ando T; Makiyama A; Yamaji K; Tamura N
Sci Rep; 2023 Feb; 13(1):2509. PubMed ID: 36782006
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Classification Criteria Performance in a Single-Center Cohort of 114 Patients With Immunoglobulin G4-Related Disease.
Spandorfer R; Ahmad M; Khosroshahi A
J Clin Rheumatol; 2023 Jan; 29(1):23-28. PubMed ID: 35905474
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease.
Ma Y; Chen L; Xu Y; Han Q; Yu B; Yuan Y; Zhao J; Yang Y; Chen J; Han F
Int J Rheum Dis; 2019 Dec; 22(12):2143-2150. PubMed ID: 31631507
[TBL] [Abstract][Full Text] [Related]
10. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
12. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS; Naden RP; Chari S; Choi HK; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Schleinitz N; Takahashi N; Umehara H; Zen Y; Stone JH;
Ann Rheum Dis; 2020 Jan; 79(1):77-87. PubMed ID: 31796497
[TBL] [Abstract][Full Text] [Related]
13. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
[TBL] [Abstract][Full Text] [Related]
14. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease.
Della-Torre E; Lanzillotta M; Germanò T; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L
Semin Arthritis Rheum; 2021 Aug; 51(4):761-765. PubMed ID: 34144386
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
16. Definite IgG4-related disease had no overlap with eosinophilic granulomatosis with polyangiitis in Korean patients: a pilot study in one centre.
Yoo J; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Oct; 39(10):3009-3015. PubMed ID: 32367405
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional pictorial review of IgG4-related disease.
Kurowecki D; Patlas MN; Haider EA; Alabousi A
Br J Radiol; 2019 Nov; 92(1103):20190448. PubMed ID: 31335170
[TBL] [Abstract][Full Text] [Related]
18. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
Hubers LM; Vos H; Schuurman AR; Erken R; Oude Elferink RP; Burgering B; van de Graaf SFJ; Beuers U
Gut; 2018 Apr; 67(4):728-735. PubMed ID: 28765476
[TBL] [Abstract][Full Text] [Related]
19. Stage classification of IgG4-related dacryoadenitis and sialadenitis by the serum cytokine environment.
Yamamoto M; Takano K; Kamekura R; Suzuki C; Ichimiya S; Himi T; Nakase H; Takahashi H
Mod Rheumatol; 2018 Nov; 28(6):1004-1008. PubMed ID: 29385874
[TBL] [Abstract][Full Text] [Related]
20. Performance of the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease in a Latin American Cohort.
Martín-Nares E; Hernández-Molina G; Baenas DF; Delgado de la Mora J; Caeiro F; Wurmann Kiblisky P; Pimentel-Quiroz VR; Ascuña Valdivia V; Faz-Munoz D; Saad EJ; Cairoli E; Elgueta Pinochet S; Madariaga Charaja H; Montante-Montes de Oca D; Gallo JR; Ugarte-Gil MF; Neira O; Burgos PI; Paira S;
J Clin Rheumatol; 2024 Mar; 30(2):52-57. PubMed ID: 38206921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
